Prolongation of Midazolam Half-Life After Sustained Infusion for Status Epilepticus
Neurol 54:1366-1368, Naritoku,D.K.&Sinha,S., 2000

Vocal Cord Adduction During Vagus Nerve Stimulation for Treatment of Epilepsy
Neurol 54:1388-1389, Zumsteg,D.,et al, 2000

Status Epilepticus Associated with Cefepime
Neurol 54:2153-2155, Dixit,S.,et al, 2000

Myoclonus Secondary to Albuterol (Salbutamol) instillation
Neurol 54:2022-2023, Micheli,F.,et al, 2000

Osteoporosis in Neurological Disorders
JNNP 68:543-549, Lloyd,M.E.,et al, 2000

Visual Impairment in Children with Epilepsy Treated with Vigabatrin
Ann Neurol 48:60-64, Gross-Tsur,V. et al, 2000

Hypothermia and Thermoregulatory Derangements Induced by Valproic Acid
Neurol 55:150-151, Zachariah,S.B. et al, 2000

Valproate, Hyperandrogenism, and Polycystic Ovaries
Arch Neurol 57:1064-1068, Isojarvi,J.I.T. & Tapanainen,J.S., 2000

Serotonin Sydrome
Medicine 79:201-209, Mason,P.J. et al, 2000

Tonic Seizures are a Particular Risk Factor for Drowning in People with Epilepsy
BMJ 321:975-976, Besag,F.M.C., 2000

Donepezil Therapy in Clinical Practice, A Randomized Crossover Study
Arch Neurol 57:94-99, Greenberg,S.M.,et al, 2000

Valproate-Induced Hyperammonemic Encephalopathy in the Presence of Topiramate
Neurol 54:230-232, Hamer,H.M.,et al, 2000

Status Epilepticus In Stroke, Report on a Hospital-Based Stroke Cohort
Neurol 54:350-354, Rumbach,L.,et al, 2000

Epilepsy, Broken Bones, and Fatty Stools
Lancet 355:1882, Drenth,J.P.H.,et al, 2000

Leukocytosis: Basics of Clinical Assessment
Am Fam Physician 62:, Abramson,N. &Melton,B., 2000

Visual Field Defects Associated with Vigabatrin Therapy
JNNP 67:716-722, Lawden,M.C.,et al, 1999

Gabapentin-Induced Anorgasmia
Neurol 53:2209, Clark,J.D.&Elliott,J., 1999

Antiepileptic Drug Regimens and Major Congenital Abnormalities in the Offspring
Ann Neurol 46:739-746, Samren,E.B.,et al, 1999

Sudden Unexpected Death in epilepsy (SUDEP): A Clinical Perspective and a Search for Risk Factors
JNNP 67:439-444,427, Kloster,R.&Engelskjon,T., 1999

Psychiatric Adverse Events During Vigabatrin Therapy
Neurol 53:1503-1511, Levinson,D.F.&Devinsky,O., 1999

Long-Term Treatment with Vagus Nerve Stimulation in Patients with Refractory Epilepsy
Neurol 53:1731-1735, Morris,G.L.,et al, 1999

Topiramate in Clinical Practice:First Year's Postlicensing Experience in a Specialist Epilepsy Clinic
JNNP 66:759-763, Kellett,M.W.,et al, 1999

Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis During First Weeks of Antiepileptic Therapy:A Case-Control Study
Lancet 353:2190-2194, Rzany,B.,et al, 1999

Safety and Efficacy of Vigabatrin and Carbamazepine in Newly Diagnosed epilepsy:A Multicentre Randomised Double-Blind Study
Lancet 354:13-19, Chadwick,D., 1999

Vigabatrin, a Gabaergic Antiepileptic Drug, Causes Concentric Visual Field Defects
Neurol 53:922-926, Kalviainen,R.,et al, 1999

Multisystem Hypersensitivity Reaction to Lamotrigine
Neurol 53:1367, Sarris,B.M.&Wong,J.G., 1999

Unilateral Pallidotomy for Parkinson's Disease:Results after More Than 1 Year
JNNP 67:511-517, Schrag,A.,et al, 1999

Drug-Induced Hypoglycemic Coma in 102 Diabetic Patients
Arch Int Med 159:281-284, Ben-Ami,H.,et al, 1999

Medical Management of Epilepsy in Adults
Neurol 51:S15-S20, Mattson,R.H., 1999

Clumsiness, Confusion, Coma, and Valproate
Lancet 353:1408, Ellaway,C.J.,et al, 1999

Open Comparative Long-Term Study of Vigabatrin vs Carbamazepine in Newly Diagnosed Partial Seizures in Children
Arch Neurol 56:605-607, Zamponi,N.&Cardinali,C., 1999

Visual Field Constriction in Children Treated with Vigabatrin
Neurol 52:1713-1714,1537, Vanhatalo,S.&Paakkonen,L., 1999

Practice Advisory:The Use of Felbamate in the Treatment of Patients with Intractable Epilepsy, Report of the quality Standards Subcommittee of the AAN and the American Epilepsy Society
Neurol 52:1540-1545, French,J.,et al, 1999

Evaluation of Refractory epilepsy Treated with Vagus Nerve Stimulation for Up to 5 Years
Neurol 52:1265-1267,1117, Ben-Menachem,E.,et al, 1999

Ventricular Asystole During Vagus Nerve Stimulation for Epilepsy in Humans
Neurol 52:1267-1269,1117, Tatum,IV,W.O.,et al, 1999

A Randomized, Placebo-Controlled Study of Topiramate in Primary Generalized Tonic-Clonic Seizures
Neurol 52:1330-1337, Biton,V.,et al, 1999

Intractable Epilepsy
Lancet 353:1238, Shuper,A.,et al, 1999

Arteriovenous Malformations of the Brain in Adults
NEJM 340:1812-1818, The Arteriovenous Malformation Study Group, 1999

Focal Lesion in the Splenium of the Corpus Callosum in Epileptic Patients:Antiepileptic Drug Toxicity
AJNR 20:125-129,131, Kim,S.S.,et al, 1999

Cognitive Effects of Topiramate,Gabapentin,And Lamotrigine in Healthy Young Adults
Neurol 52:321-327, Martin,R.,et al, 1999

Risk Factors for Sudden Unexpected Death in epilepsy:A Case-Control Study
Lancet 353:888-893, Nilsson,L.,et al, 1999

Lamotrigine-Induced Tourettism
Neurol 52:1191-1194, Lombroso,C.T., 1999

Drug Interactions with Methadone
Presse Med 27:1381-1384, Schlatter,J.,et al, 1999

Oxcarbazepine: Double-blind, Randomized, Placebo-control, Monotherapy Trial for Partial Seizures
Neurol 52:732-737, Schachter,S.C. et al, 1999

Incidence and Clinical Consequence of the Purple Glove Syndrome in Patients Receiving Intravenous Phenytoin
Neurol 51:1034-1039,942, O'Brien,T.J.,et al, 1998

Population-based Study of the Incidence of Sudden Unexplained Death in Epilepsy
Neurol 51:1270-1274, Ficker,D.M.,et al, 1998

Management Issues for Women with Epilepsy,A Review of the Literature
Neurol 51:949-956, Zahn,C.A.,et al, 1998

Practice Parameter,Management Issues for Women with Epilepsy (Summary Statement)
Neurol 51:944-948, Rpt of the Quality Stnds Subcmte AAN, 1998

Vigabatrin-Associated Retinal Cone System Dysfunction, Electroretinogram & Ophthalmol Findings
Neurol 50:614-618, Krauss,G.L.,et al, 1998

Electrical Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease
NEJM 339:1105-1111, Limousin,P.,et al, 1998